Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of BIOCON . For more details, see the BIOCON quarterly results and BIOCON share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.3 |
No. of shares | m | 1,200.60 |
1 Week | % | 14.9 |
1 Month | % | 19.0 |
1 Year | % | 33.0 |
52 week H/L | Rs | 313.4/217.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BIOCON EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 718 | 636 | 488 | 424 | 388 | |
Low | Rs | 544 | 211 | 275 | 315 | 192 | |
Sales per share (Unadj.) | Rs | 91.9 | 52.5 | 59.5 | 68.2 | 93.1 | |
Earnings per share (Unadj.) | Rs | 16.7 | 7.5 | 7.1 | 6.4 | 5.4 | |
Diluted earnings per share | Rs | 8.4 | 7.5 | 7.0 | 6.4 | 5.4 | |
Cash flow per share (Unadj.) | Rs | 24.2 | 12.1 | 13.0 | 13.2 | 14.6 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0 | 0 | 0.50 | 1.50 | |
Adj. dividends per share | Rs | 0.50 | 0.00 | 0.00 | 0.50 | 1.50 | |
Avg Dividend yield | % | 0.2 | 0 | 0 | 0.1 | 0.5 | |
Book value per share (Unadj.) | Rs | 100.3 | 55.0 | 62.3 | 68.5 | 146.5 | |
Adj. book value per share | Rs | 50.1 | 54.9 | 62.2 | 68.5 | 146.5 | |
Shares outstanding (eoy) | m | 600.00 | 1,200.00 | 1,200.00 | 1,200.60 | 1,200.60 | |
Price / Sales ratio | x | 6.9 | 8.1 | 6.4 | 5.4 | 3.1 | |
Avg P/E ratio | x | 37.8 | 56.5 | 54.0 | 57.5 | 54.1 | |
P/CF ratio (eoy) | x | 26.1 | 35.0 | 29.3 | 28.0 | 19.8 | |
Price / Book Value ratio | x | 6.3 | 7.7 | 6.1 | 5.4 | 2.0 | |
Dividend payout | % | 6.0 | 0 | 0 | 7.8 | 28.0 | |
Avg Mkt Cap | Rs m | 378,645 | 508,380 | 457,350 | 443,622 | 347,814 | |
Total wages/salary | Rs m | 11,653 | 14,588 | 17,410 | 18,801 | 21,810 |
BIOCON INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 55,144 | 63,005 | 71,431 | 81,840 | 111,742 | |
Other income | Rs m | 4,143 | 5,075 | 6,052 | 6,903 | 7,681 | |
Total revenues | Rs m | 59,287 | 68,080 | 77,483 | 88,743 | 119,423 | |
Gross profit | Rs m | 13,193 | 13,245 | 12,353 | 11,746 | 16,611 | |
Depreciation | Rs m | 4,478 | 5,522 | 7,151 | 8,142 | 11,131 | |
Interest | Rs m | 709 | 649 | 577 | 676 | 4,190 | |
Profit before tax | Rs m | 12,149 | 12,149 | 10,677 | 9,831 | 8,971 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,123 | 3,151 | 2,215 | 2,115 | 2,541 | |
Profit after tax | Rs m | 10,026 | 8,998 | 8,462 | 7,716 | 6,430 | |
Gross profit margin | % | 23.9 | 21.0 | 17.3 | 14.4 | 14.9 | |
Effective tax rate | % | 17.5 | 25.9 | 20.7 | 21.5 | 28.3 | |
Net profit margin | % | 18.2 | 14.3 | 11.8 | 9.4 | 5.8 |
BIOCON BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 48,885 | 53,250 | 75,482 | 83,823 | 123,340 | |
Current liabilities | Rs m | 30,385 | 40,080 | 41,697 | 38,280 | 85,107 | |
Net working cap to sales | % | 33.5 | 20.9 | 47.3 | 55.6 | 34.2 | |
Current ratio | x | 1.6 | 1.3 | 1.8 | 2.2 | 1.4 | |
Inventory Days | Days | 95 | 83 | 136 | 101 | 129 | |
Debtors Days | Days | 86 | 71 | 77 | 92 | 117 | |
Net fixed assets | Rs m | 69,792 | 87,508 | 106,142 | 117,184 | 394,078 | |
Share capital | Rs m | 3,000 | 6,000 | 6,000 | 6,003 | 6,003 | |
"Free" reserves | Rs m | 57,208 | 59,970 | 68,728 | 76,281 | 169,926 | |
Net worth | Rs m | 60,208 | 65,970 | 74,728 | 82,284 | 175,929 | |
Long term debt | Rs m | 15,256 | 12,222 | 29,616 | 39,985 | 152,905 | |
Total assets | Rs m | 118,677 | 140,758 | 182,146 | 201,007 | 517,418 | |
Interest coverage | x | 18.1 | 19.7 | 19.5 | 15.5 | 3.1 | |
Debt to equity ratio | x | 0.3 | 0.2 | 0.4 | 0.5 | 0.9 | |
Sales to assets ratio | x | 0.5 | 0.4 | 0.4 | 0.4 | 0.2 | |
Return on assets | % | 9.0 | 6.9 | 5.0 | 4.2 | 2.1 | |
Return on equity | % | 16.7 | 13.6 | 11.3 | 9.4 | 3.7 | |
Return on capital | % | 17.0 | 16.4 | 10.8 | 8.6 | 4.0 | |
Exports to sales | % | 28.1 | 18.7 | 16.5 | 3.1 | 3.1 | |
Imports to sales | % | 18.9 | 13.4 | 7.1 | 7.8 | 6.0 | |
Exports (fob) | Rs m | 15,506 | 11,753 | 11,791 | 2,525 | 3,467 | |
Imports (cif) | Rs m | 10,399 | 8,474 | 5,084 | 6,360 | 6,654 | |
Fx inflow | Rs m | 15,506 | 11,753 | 11,791 | 2,525 | 3,467 | |
Fx outflow | Rs m | 10,399 | 8,474 | 5,084 | 6,360 | 6,654 | |
Net fx | Rs m | 5,107 | 3,279 | 6,707 | -3,835 | -3,187 |
BIOCON CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 11,546 | 12,831 | 11,597 | 11,766 | 18,525 | |
From Investments | Rs m | -7,138 | -15,589 | -36,247 | -16,991 | -142,818 | |
From Financial Activity | Rs m | -2,417 | 3,876 | 25,640 | 2,421 | 130,487 | |
Net Cashflow | Rs m | 2,103 | 1,654 | 723 | -2,433 | 6,411 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Kiran Mazumdar-Shaw | COMP SEC: Mayank Verma | YEAR OF INC: 1978 | BSE CODE: 532523 | FV (Rs): 5 | DIV YIELD (%): 0.5 |
Read: BIOCON 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BIOCON With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.